RE:ADTX.....There is a filing that one should be cognizant of..Iseneschal wrote: https://www.sec.gov/Archives/edgar/data/1726711/999999999524002845/xslEFFECTX01/primary_doc.xml
It's a double edged sword......most times there should be a major "pump" to inflate the sh price.....some times they drive the sh price down
Ya pays yo money & yo takes yo chances
Right from "the horses mouth"......as I mentioned ; )
Aditxt Delivers Shareholder Update and 2024 Year-End Plan
2024-10-03 05:15 ET - News Release
Acquisition target Evofem reported revenue of $7.8 million for the six months ended June 30, 2024
Acquisition target Appili has received approximately $6.0 million of the total $14.0 million to date in a non-dilutive funding commitment from DoD
Shelf registration statement and resale registration statement for Equity Line of Credit declared Effective by the SEC
Effected a 1-for-40 reverse split of its common stock, which was primarily intended to regain compliance with Nasdaq’s minimum bid price requirement
MOUNTAIN VIEW, Calif. -- (Business Wire)
Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation platform dedicated to accelerating promising health innovations, today provided an update on its plans for 2024 year-end.